alicon AG - breakthrough products setting a new standard in TSE diagnostics and prion filtration


Excerpted from the website:

The Swiss biotechnology company alicon AG, founded in 2004, specializes in developing innovative technologies to detect and filtrate pathogenic prions in blood from animals and humans.
Within the diagnostic sector, alicon is particularly active and well-positioned as a pioneer in developing the first ante mortem TSE testing procedures. The firm’s business concept is based on the design of a novel process that can confirm the presence of prions in blood from humans and animals.
In the bio-safety sector, alicon is developing procedures allowing filtration of prions from blood plasma products and culture medium.

read more

Additional Information

Domain Resolution

This domain resolves to the following IP addresses:

Retrieved from ""